123 related articles for article (PubMed ID: 17673329)
21. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
22. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.
Abásolo L; Júdez E; Descalzo MA; González-Alvaro I; Jover JA; Carmona L;
Semin Arthritis Rheum; 2008 Jun; 37(6):388-97. PubMed ID: 17977580
[TBL] [Abstract][Full Text] [Related]
23. Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.
Martin RW; Head AJ; René J; Swartz TJ; Fiechtner JJ; McIntosh BA; Holmes-Rovner M
J Rheumatol; 2008 Apr; 35(4):618-24. PubMed ID: 18278840
[TBL] [Abstract][Full Text] [Related]
24. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.
Roussy JP; Bessette L; Bernatsky S; Rahme E; Lachaine J
Osteoporos Int; 2013 Sep; 24(9):2483-92. PubMed ID: 23504029
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
[TBL] [Abstract][Full Text] [Related]
26. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
Odegård S; Kvien TK; Uhlig T
J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
[TBL] [Abstract][Full Text] [Related]
27. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
[TBL] [Abstract][Full Text] [Related]
28. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.
Widdifield J; Bernatsky S; Paterson JM; Gunraj N; Thorne JC; Pope J; Cividino A; Bombardier C
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):353-61. PubMed ID: 22833532
[TBL] [Abstract][Full Text] [Related]
29. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee.
Matteson EL; Hickey AR; Maguire L; Tilson HH; Urowitz MB
J Rheumatol; 1991 Jun; 18(6):809-14. PubMed ID: 1895261
[TBL] [Abstract][Full Text] [Related]
31. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
32. Intensifying treatment of rheumatoid arthritis with combinations of traditional disease-modifying anti-rheumatic drugs among patients with persistent disease did not reduce the need for large joint surgery.
Kononoff A; Heiskanen J; Lumiaho J; Kautiainen H; Kaipiainen-Seppänen O
Scand J Rheumatol; 2007; 36(6):424-7. PubMed ID: 18092262
[TBL] [Abstract][Full Text] [Related]
33. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer in systemic lupus erythematosus.
Bin J; Bernatsky S; Gordon C; Boivin JF; Ginzler E; Gladman D; Fortin PR; Urowitz M; Manzi S; Isenberg D; Rahman A; Petri M; Nived O; Sturfeldt G; Ramsey-Goldman R; Clarke AE
Lung Cancer; 2007 Jun; 56(3):303-6. PubMed ID: 17291624
[TBL] [Abstract][Full Text] [Related]
35. DMARDS and infections in rheumatoid arthritis.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Montecucco C
Autoimmun Rev; 2008 Dec; 8(2):139-43. PubMed ID: 19014871
[TBL] [Abstract][Full Text] [Related]
36. [Pneumonia in patients with rheumatoid arthritis: the frequency of development, the specific features of its course and risk factors].
Polianskaia MV; Belov BS; Balabanova RM
Ter Arkh; 2010; 82(5):29-33. PubMed ID: 20597267
[TBL] [Abstract][Full Text] [Related]
37. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
38. Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.
Suarez-Almazor ME; Berrios-Rivera JP; Cox V; Janssen NM; Marcus DM; Sessoms S
J Rheumatol; 2007 Dec; 34(12):2400-7. PubMed ID: 17985405
[TBL] [Abstract][Full Text] [Related]
39. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
Chan G; Goh F; Hodgson T; Hsu E; Johnstone D; Ly J; Platt T; Rodrigues E; Tsai W; Hider P; Gray A; Highton J
N Z Med J; 2008 May; 121(1274):34-41. PubMed ID: 18535644
[TBL] [Abstract][Full Text] [Related]
40. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.
Widdifield J; Bernatsky S; Paterson JM; Thorne JC; Cividino A; Pope J; Gunraj N; Bombardier C
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):53-7. PubMed ID: 20806274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
